Search Results for: Global Type 2 Diabetes Market
Articles
May 6, 2012
Royalty Pharma Buys an Interest in Fumaderm for $761 Million May 6, 2012
Royalty Pharma recently announced it had acquired an interest in the earn-out payable to the former shareholders of Fumapharm AG...
March 7, 2012
Study Establishes XMetA as the First Allosteric Insulin Receptor-Activating Antibody to Improve Glycemic Control In Vivo March 7, 2012
XOMA Corporation recently announced its study of XMetA, the company's fully human allosteric monoclonal antibody to the insulin receptor, is...
February 5, 2012
Alize Pharma Licenses ASPAREC Therapy for ALL to EUSA Pharma February 5, 2012
Alize Pharma II, recently announced the signing of a licensing agreement with EUSA Pharma for ASPAREC, a new L-asparaginase product...
August 4, 2011
Ironwood & Depomed Announce Collaboration, Research & License Agreement August 4, 2011
Ironwood Pharmaceuticals, Inc. and Depomed, Inc. recently announced that Ironwood has licensed worldwide rights to utilize Depomed's Acuform gastric-retentive drug...Issues
May 2, 2018